Hospital
Community Memorial Health System
Community Memorial Health System was paid $2.12M by Medicaid between Jan 2018 and Oct 2024, across 100 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.
33Billing provider infoCOMMUNITY MEMORIAL HEALTH SYSTEM
OJAI, CA 93023
OJAI, CA 93023
33aNPI1992876767assigned 11/13/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$2.12M
24GClaims77,555
24DCodes billed100
24AFirst – last monthJan 2018 – Oct 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,695 | $297K | |
| 2019 | 12,605 | $275K | |
| 2020 | 7,774 | $194K | |
| 2021 | 9,500 | $296K | |
| 2022 | 11,256 | $352K | |
| 2023 | 14,153 | $465K | |
| 2024incomplete | 8,572 | $244K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 6,358 | 5,739 | $359K |
| 0450 | Emergency room services | 15% | 7,116 | 6,414 | $319K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8.2% | 2,527 | 2,285 | $174K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.3% | 460 | 454 | $134K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4.1% | 1,727 | 1,579 | $87K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.6% | 644 | 620 | $77K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.4% | 1,850 | 1,708 | $73K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.2% | 2,786 | 2,537 | $69K |
| 80053 | Comprehensive metabolic panel | 3.1% | 5,921 | 5,406 | $66K |
| 87631 | 2.8% | 917 | 884 | $59K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.8% | 1,227 | 1,081 | $59K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.6% | 1,855 | 1,606 | $54K |
88 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.2% | 1,725 | $46K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.1% | 1,681 | $45K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.0% | 803 | $43K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 493 | $39K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.7% | 583 | $36K |
| 71046 | Radiologic examination, chest; 2 views | 1.6% | 1,290 | $34K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 6,071 | $34K |
| 97139 | 1.6% | 1,147 | $34K | |
| 99283 | Emergency room visit (moderate) | 1.2% | 450 | $26K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 2,104 | $25K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 266 | $15K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 43 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,569 | $14K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 942 | $13K |
| 84484 | <1% | 1,844 | $11K | |
| 83690 | <1% | 2,167 | $11K | |
| 0760 | <1% | 247 | $10K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,521 | $10K |
| 80061 | Lipid panel | <1% | 851 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,462 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 632 | $8K |
| J3490 | Unclassified drugs | <1% | 359 | $8K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 155 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 131 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 657 | $6K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 184 | $6K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 204 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 351 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,420 | $5K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,492 | $4K |
| 84703 | <1% | 723 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 69 | $4K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 77 | $4K |
| 85027 | <1% | 695 | $3K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 375 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 70 | $2K |
| 81015 | <1% | 917 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 166 | $2K |
| Z7502 | <1% | 43 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 241 | $2K |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 1,287 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 14 | $2K |
| 85610 | <1% | 686 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 24 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 16 | $1K |
| 90715 | <1% | 36 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 12 | $1K |
| 87077 | <1% | 224 | $1K | |
| 73030 | <1% | 39 | $914.36 | |
| 87186 | <1% | 165 | $882.05 | |
| 85730 | <1% | 251 | $868.60 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 107 | $821.00 |
| 87430 | <1% | 102 | $808.20 | |
| 73630 | <1% | 26 | $724.55 | |
| 73610 | <1% | 24 | $678.12 | |
| 83605 | <1% | 88 | $674.89 | |
| 73562 | <1% | 15 | $450.77 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $426.02 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $424.62 |
| 87040 | <1% | 43 | $410.19 | |
| 73130 | <1% | 15 | $409.61 | |
| 81001 | <1% | 187 | $396.41 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 55 | $391.70 |
| 72100 | <1% | 12 | $391.41 | |
| 85379 | <1% | 71 | $386.57 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 25 | $321.00 |
| A4649 | Surgical supply; miscellaneous | <1% | 3,496 | $203.26 |
| 86803 | <1% | 12 | $147.24 | |
| 86780 | <1% | 13 | $144.69 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 26 | $139.44 |
| 82150 | <1% | 27 | $124.38 | |
| 83880 | <1% | 12 | $117.72 | |
| 85014 | <1% | 106 | $117.25 | |
| 85018 | <1% | 106 | $116.08 | |
| 83735 | <1% | 28 | $108.80 | |
| 86701 | <1% | 14 | $108.08 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 14 | $102.23 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 16 | $99.74 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 26 | $93.76 |
| 82948 | <1% | 27 | $73.20 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 13 | $63.84 |
| 88142 | <1% | 12 | $53.64 | |
| 81003 | <1% | 13 | $17.28 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 68 | $13.41 |
| 0259 | <1% | 227 | $8.98 | |
| 0637 | <1% | 46 | $7.23 | |
| 0270 | <1% | 81 | $2.61 | |
| 0250 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZDEBLICK, MICHAEL (PRESIDENT & CEO)
Parent organizationCOMMUNITY MEMORIAL HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| Community Memorial Health System | Ventura, CA | $94.18M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.